Boji Medical Technology Co (SZSE:300404) ROCE % : 6.29% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Boji Medical Technology Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Boji Medical Technology Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 6.29%.

Boji Medical Technology Co ROCE % Historical Data

The historical data trend for Boji Medical Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boji Medical Technology Co ROCE % Chart

Boji Medical Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

2.87

6.04

7.07

2.76

1.88

Boji Medical Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															5.35	1.05	1.00	0.36	6.29

Boji Medical Technology Co ROCE % Calculation

Boji Medical Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	19.165	/	( ( (1265.425 - 300.193)	+	(1428.927 - 357.51) )	/ 2 )
	=	19.165	/	( (965.232	+	1071.417)	/ 2 )
	=	19.165	/	1018.3245
	=	1.88 %

Boji Medical Technology Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	67.632	/	( ( (1428.927 - 357.51)	+	(1451.05 - 370.63) )	/ 2 )
	=	67.632	/	( ( 1071.417	+	1080.42 )	/ 2 )
	=	67.632	/	1075.9185
	=	6.29 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Boji Medical Technology Co (SZSE:300404) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Boji Medical Technology Co ROCE % Related Terms

Thank you for viewing the detailed overview of Boji Medical Technology Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Boji Medical Technology Co (SZSE:300404) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boji Medical Technology Co Ltd (SZSE:300404) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nanxiang 1st Road, Building No. 62, Science City, Huangpu District, Guangdong Province, Guangzhou, CHN, 510640

Website

http://www.gzboji.com

Boji Medical Technology Co Ltd is engaged in offering service of outsourcing drug research and development. Its services include drug research and development which are new drug research and activity screening, pharmaceutical research, drug evaluation Price, clinical research, technological achievements transformation services and pre-clinical independent research and development.

Boji Medical Technology Co (SZSE:300404) Headlines

No Headlines